Eunsik Lee

Eunsik Lee

Auto-generated profile, based on publicly available information

Eunsik Lee

Department of Urology, Seoul National University Hospital, Seoul, Korea

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2005 in BJU International
Verified
Journal Article
Closed access
PDF file
SBSeok‐Soo Byun
Seok‐Soo Byun
SKSoo W. Kim
Soo W. Kim
HCHwang Choi
Hwang Choi
CLChongwook Lee
Chongwook Lee
ELEunsik Lee
Eunsik Lee

29 July 2009 in International Journal of Urology
Verified
Journal Article
Closed access
PDF file
HJHwang Gyun Jeon
Hwang Gyun Jeon
JBJungbum Bae
Jungbum Bae
JYJun‐Seok Yi
Jun‐Seok Yi
IHIn Sik Hwang
In Sik Hwang
SLSang Eun Lee
Sang Eun Lee
ELEunsik Lee
Eunsik Lee

3 May 2014 in Japanese Journal of Clinical Oncology
Verified
Journal Article
Open access
PDF file
SKSung Han Kim
Sung Han Kim
AYAmi Yu
Ami Yu
JJJae Hyun Jung
Jae Hyun Jung
YLYoung Ju Lee
Young Ju Lee
ELEun-Sik Lee
Eun-Sik Lee
We report on the short and late morbidity and mortality of ileal conduit and neobladder after radical cystectomy with their associated risk factors. We retrospectively collected data on 308 non-metastatic bladder cancer patients who underwent radical cystectomy with either ileal conduit or neobladder for a curative intent from January 1999 to December 2011. Post-operative morbidity and mortality of 30-day (early) and 90-day (late) complication with their risk factors were examined in association with different types of urinary diversion. A comparative analysis using propensity-score matching was performed with matching variables of age, sex, number of underlying diseases and pathologic T and N stages, lymph node dissection, operative time and time of surgical year for comparison of the early and late morbidities between ileal conduit and neobladder. During the median follow-up of 46.6 months, early and late morbidities were 29.5% (n = 91) and 19.8% (n = 61), and complication-related mortalities were 2.2 and 6.6%, respectively. The type of urinary diversion significantly affected only the late complications (early: neobladder 57 vs. ileal conduit 47, P = 0.096; late: neobladder 67 vs. ileal conduit 37, P < 0.001). However, after propensity-score matching, no significant differences in early and late morbidities were observed between neobladder and ileal conduit. For risk factors of morbidity, number of removed lymph node states and hypertension were independently significant for both early and late complications (P < 0.05). The type of urinary diversion affected only late complication, however, results of the matching analysis showed no significant differences in early and late morbidities between neobladder and ileal conduit .

1 December 2002 in Journal of International Medical Research
Verified
Journal Article
Closed access
PDF file
ELE Lee
E Lee
Tamsulosin (0.2 mg) and finasteride (5 mg) once daily for 24 weeks were compared in a single-blind, randomized study as initial treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH) in 205 Korean patients. Symptom and quality of life (QOL) assessment by the International Prostatic Symptom Score (I-PSS), maximum urinary flow rate ( Qmax) and adverse events were analysed at 4 weeks and 24 weeks. On intention-to-treat analysis, both drugs showed similar efficacy at endpoint (decreased I-PSS, increased Qmax and improved QOL score; 34.7%, 23.9% and 34.1% for tamsulosin, and 30.5%, 22.2% and 23.1% for finasteride, respectively). However, tamsulosin produced significant improvements in I-PSS and Qmax at 4 weeks compared with finasteride (17.6% versus 10.0% and 10.9% versus 3.1%, respectively), and a superior QOL score improvement during the study. Adverse events were observed significantly more frequently among finasteride than tamsulosin patients (23 versus four). Both were equally effective in long-term treatment of urinary outflow obstruction symptoms associated with BPH in Korean patients, but tamsulosin was more effective for short-term treatment, with a better safety profile.

15 November 2011 in BJU International
Verified
Journal Article
Closed access
PDF file
SLSangchul Lee
Sangchul Lee
HJHwang Gyun Jeon
Hwang Gyun Jeon
CKCheol Kwak
Cheol Kwak
HKHyeon Hoe Kim
Hyeon Hoe Kim
SBSeok‐Soo Byun
Seok‐Soo Byun
ELEunsik Lee
Eunsik Lee

1 May 2009 in Human Pathology
Verified
Journal Article
Closed access
PDF file
IJIn Gab Jeong
In Gab Jeong
SKSung Han Kim
Sung Han Kim
HJHwang Gyun Jeon
Hwang Gyun Jeon
BKBaek Hee Kim
Baek Hee Kim
KMKyung Chul Moon
Kyung Chul Moon
ELEunsik Lee
Eunsik Lee